Bing found the following results
ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor
Navitoclax - Wikipedia
5月21日 慢性腎臓病(CKD)と細胞老化(5月19日号 Science ...
Bcl-2/Bcl-xL inhibitor ABT-263 overcomes hypoxia-driven ...
Navitoclax (ABT-263) | ≥99%(HPLC) | Selleck | Bcl-2 阻害剤
ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor
Targeting anti-apoptotic pathways eliminates senescent ...
ABT-263 induces G1/G0-phase arrest, apoptosis and ...
ABT-263 Reduces Hypertrophic Scars by Targeting Apoptosis ...
Discovery of ABT-263, a Bcl-family protein inhibitor ...